SWOG clinical trial number
SWOG-8244
The Clinical Antitumor Activity of Vinblastine Sulfate in Diffuse Mesothelioma
Closed
Phase
Published
Abbreviated Title
The Clinical Antitumor Activity of Vinblastine Sulfate in Diffuse Mesothelioma
Activated
02/18/1983
Closed
03/20/1986
Publication Information Expand/Collapse
1988
Phase II trial of five day intravenous infusion vinblastinesulfate in patients with diffuse malignant mesothelioma. A SouthwestOncology Group study.